Envista Holdings Co. (NYSE:NVST) Position Raised by First Hawaiian Bank

First Hawaiian Bank raised its stake in Envista Holdings Co. (NYSE:NVST) by 19.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 32,285 shares of the company’s stock after buying an additional 5,363 shares during the quarter. First Hawaiian Bank’s holdings in Envista were worth $623,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Envista during the third quarter valued at about $31,000. GAMMA Investing LLC raised its stake in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares in the last quarter. Huntington National Bank raised its stake in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after purchasing an additional 949 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its stake in shares of Envista by 50.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after purchasing an additional 728 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Mizuho assumed coverage on shares of Envista in a research note on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price objective on the stock. Robert W. Baird boosted their price target on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Piper Sandler boosted their price target on shares of Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Finally, Wells Fargo & Company started coverage on shares of Envista in a research report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price target on the stock. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.21.

Envista Trading Down 3.0 %

NYSE:NVST opened at $18.60 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $25.45. The stock’s 50-day moving average is $20.19 and its two-hundred day moving average is $18.58. The stock has a market cap of $3.20 billion, a PE ratio of -2.39, a price-to-earnings-growth ratio of 2.71 and a beta of 1.33.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.09 by $0.03. The business had revenue of $601.00 million during the quarter, compared to analysts’ expectations of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm’s quarterly revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.43 EPS. As a group, equities research analysts forecast that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.